Rosetta Genomics Ltd. (USA) Share Price Nasdaq
Equities
IL0011026494
Biotechnology & Medical Research
Sales 2015 | 8.27M 690M | Sales 2016 | 9.23M 771M | Capitalization | 9.22M 770M |
---|---|---|---|---|---|
Net income 2015 | -17M -1.42B | Net income 2016 | -16M -1.34B | EV / Sales 2015 | 1.07 x |
Net cash position 2015 | 13.54M 1.13B | Net cash position 2016 | 2.45M 204M | EV / Sales 2016 | 0.73 x |
P/E ratio 2015 |
-1.07
x | P/E ratio 2016 |
-0.54
x | Employees | - |
Yield 2015 * |
-
| Yield 2016 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Ron Kalfus
DFI | Director of Finance/CFO | 50 | 24/12/24 |
Nicole Massoll
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
David Sidransky
BRD | Director/Board Member | 64 | 22/09/22 |
1st Jan change | Capi. | |
---|---|---|
+1.77% | 42.86B | |
+47.70% | 41.36B | |
+12.24% | 42.74B | |
-8.83% | 27.68B | |
+7.44% | 25.15B | |
-23.01% | 18.63B | |
+30.56% | 12.37B | |
-1.82% | 11.92B | |
+8.35% | 11.21B |